Hematology

COVID-19

Questions discussed in this category

Is rituximab for refractory ITP contraindicated in the setting of an active COVID infection, particularly in a patient with asymptomatic COVID?

2 Answers available

In a patient with a bleeding disorder, how would one approach anticoagulation during active COVID infection?

Bleeding disorder such as vWD

1 Answer available

How has the virtual aspect of tumor boards impacted their educational quality in the Covid-19 era?

1 Answer available

Do you recommend routine use of Evusheld for pre-exposure prophylaxis for patients on immunosuppression?

Does treatment with B-cell depletion and/or negative anti-spike antibody status despite COVID mRNA vaccination influence your decision?

1 Answer available

How have you been counseling patients with sickle cell regarding a 3rd COVID vaccine?

3 Answers available

Should we recommend the COVID-19 booster vaccine to patients who had a DVT or any other complications such as hemolytic anemia or thrombocytopenia from prior vaccine doses?

2 Answers available

In a patient with a heterozygous prothrombin gene mutation who has COVID with minimal symptoms, do you recommend prophylactic and/or therapeutic anticoagulation?

1 Answer available

Are there any alternative, hypofractionated RT courses for patients with DLBCL that can be used during the COVID-19 pandemic?

2 Answers available

Do you routinely check platelet counts after COVID-19 vaccines in patients with chronic ITP?

1 Answer available

Do you recommend COVID vaccination in patients with antiphospholipid antibody positivity or other prothrombotic states not on anti-coagulation?

1 Answer available

What hematologic conditions are contraindications for a COVID vaccine?

2 Answers available

How do you advise a patient with VTE on indefinite anticoagulants regarding the Ad26.COV2.S Johnson & Johnson/Janssen COVID vaccine?

1 Answer available

In patients with a history of HIT, how do you counsel them on the use of the AstraZeneca vaccine given reports of unusual thrombosis and association with PF4/heparin antibodies?

AstraZeneca may cause PF4 antibodies leading to vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).

1 Answer available

What are the current official guidelines regarding COVID-19 vaccination for patients with cancer or for hematologic conditions?

2 Answers available

How would you time COVID-19 vaccination with someone on R-CHOP chemotherapy?

1 Answer available

What is the optimal VTE prophylaxis for hospitalized patients with COVID-19?

Should we use a different dose in critically ill patients in the ICU? When should we consider intermediate-dose anticoagulation?

1 Answer available

Do you recommend that children with sickle cell disease refrain from returning to school during the COVID-19 pandemic?

2 Answers available

Would you stop current immunosuppressive therapy or delay starting immunosuppressive therapy in a patient with aplastic anemia who has been infected with COVID-19?

2 Answers available

Would you recommend anticoagulation prophylaxis for a pediatric patient admitted with COVID-19?

3 Answers available

Are patients with bleeding disorders receiving plasma-derived products at increased risk of acquiring COVID-19?

1 Answer available

Should patients with bleeding disorders increase their home supplies of clotting factors foreseeing a possible shortage of product availability due to COVID-19?

1 Answer available

How would you manage a patient with sickle cell disease who is infected with COVID-19?

1 Answer available

Papers discussed in this category

Acta Paediatr., 2020 Mar 23

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.

N Engl J Med, 2021 Apr 14

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.

Semin Hematol,

Epidemiology and risk factors for venous thrombosis.

Am J Hematol, 2021 Jun 29

BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies.

Blood, 2010-11-04

Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease.

Pediatric blood & cancer, 2014-05

Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease.

British journal of haematology, 2015-05

Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy.

Oman Med J, 2020 Nov 07

Respiratory Viral Infections in Sickle Cell Anemia: Special Emphasis on H1N1 Co-infection.

Pediatr Blood Cancer, 2020 Sep 08

Fatal viral infections in hemoglobin sickle cell C patients.

Blood Adv,

COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals.

Hemoglobin, 2021 May 24

Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.

Thromb Res, 2021 Jun 25

Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study.

Hematology

COVID-19

Questions discussed in this category

Papers discussed in this category

Related Topics in Hematology